Description Total budget of the call: EUR 679.3 million
The research priorities for 2013 are: brain research, antimicrobial drug resistance and comparative effectiveness research, complemented by topics from other areas such as developing personalised medicines approaches, cardiovascular research, safety and efficacy of therapies, cancer and public health research and a horizontal activity for translating research results into innovative applications for health.
This activity aims at supporting innovation through the exploitation and dissemination of results from FP funded projects and their transfer into innovative applications and policies.
Eligibility:
There must be at least three "legal entities" established in different EU Member States or Associated countries. The entities must be independent of each other.
The EU Member States are:
Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United
Kingdom.
The Associated Countries are:
Albania, Bosnia and Herzegovina, Croatia, Faroe Islands, FYR Macedonia, Iceland, Israel, Liechtenstein, Moldova, Montenegro, Norway, Serbia, Switzerland and Turkey
Target audience:
Research institutes, Universities, Industry, including SMEs, (Possibly) Potential end-users
Budget:
Total budget of the call: 679.3 million Euros
Deadline: 2 October 2012
For more info click here